23.01.2020 • NewsElaine BurridgeItalmatchICL

Italmatch Buys ICL’s Phosphorus Process

Italmatch Buys ICL’s Phosphorus Process
Italmatch Buys ICL’s Phosphorus Process

Italian specialty chemicals company Italmatch Chemicals has acquired Israel Chemicals’ (ICL) phosphorus recovery process, known as RecoPhos Project Technology. The deal includes all licenses, intellectual property, know-how and related assets. Financial terms were not disclosed.

Italmatch intends to develop and complete a “sustainable, highly efficient and economically viable” process to recover phosphorus from waste streams, including ash from sewage sludge, effectively opening a new route to producing elemental phosphorus from secondary “waste” raw materials.

The technology, the company said, will replace the need to use natural phosphate ore, which the EU has declared as a critical and strategic raw material because of its limited availability in the long-term.

“This acquisition not only introduces a new way to treat waste streams containing phosphorus, but also transforms the way the industry will treat phosphorus-containing ashes in the future,” said Carlos Galeano, Italmatch’s Beyond Innovation project director. “With Recophos, Italmatch Chemicals aims to both offer a P4 (elemental phosphorus) with a considerably higher quality to the market and consolidate its global leadership in the high-tech industry.”

Phosphorus is a key raw material for different industrial applications in fields such as flame retardants, oil additives, crop protection, pharmaceuticals and electronics, among others.

 

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.